Sandoz is the generic and biosimilar division of the Novartis group. The Novartis UK press office can be contacted on: +44 1276 698691
Media requests can also be sent via email to: [email protected]
Please note that this service handles press enquiries from journalists only. If you require information or advice about your medication or treatment please contact your healthcare professional.
For non-media-related enquiries, please call the SandozUK switchboard on +44 1276 698020 or find contact details for our UK business and sites here.
UK/KT/SDZ/17-0047(1) June 2019
Modern Slavery Act
This site is intended for a UK audience